Moderna, Inc. - COMMON STOCK (MRNA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
MRNA on Nasdaq
Shares outstanding
384,509,293
Price per share
$29.49
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
274,563,704
Total reported value
$7,091,157,324
% of total 13F portfolios
0%
Share change
-16,974,668
Value change
-$451,925,470
Number of holders
626
Price from insider filings
$29.49
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Moderna, Inc. - COMMON STOCK (MRNA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAILLIE GIFFORD & CO 6.5% -36% $665,378,042 -$371,806,817 24,948,558 -36% BAILLIE GIFFORD & CO 31 Mar 2025
FMR LLC 3.2% -38% $317,820,001 -$227,968,658 12,304,297 -42% FMR LLC 30 Sep 2025

As of 30 Sep 2025, 626 institutional investors reported holding 274,563,704 shares of Moderna, Inc. - COMMON STOCK (MRNA). This represents 71% of the company’s total 384,509,293 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Moderna, Inc. - COMMON STOCK (MRNA) together control 56% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 11% 41,185,295 -1.3% 0.02% $1,063,816,169
BlackRock, Inc. 7.7% 29,527,917 +3.2% 0.01% $762,706,089
BAILLIE GIFFORD & CO 5.7% 21,846,666 -1.1% 0.42% $564,299,382
STATE STREET CORP 4.4% 17,108,595 -0.94% 0.02% $441,915,009
FMR LLC 3.2% 12,304,297 -37% 0.02% $317,820,001
MORGAN STANLEY 2.6% 9,962,232 +23% 0.02% $257,324,501
GEODE CAPITAL MANAGEMENT, LLC 2.4% 9,249,352 +4.2% 0.02% $238,477,440
Invesco Ltd. 2.1% 8,216,163 +16% 0.03% $212,223,494
Theleme Partners LLP 2.1% 8,068,810 +2.5% 13% $208,417,362
TWO SIGMA INVESTMENTS, LP 2% 7,529,981 +8.2% 0.3% $194,499,409
TWO SIGMA ADVISERS, LP 1.8% 6,772,900 -13% 0.35% $174,944,007
D. E. Shaw & Co., Inc. 1.6% 6,146,374 -18% 0.13% $158,760,840
UBS Group AG 1.2% 4,801,547 +22% 0.02% $124,023,958
Flagship Pioneering Inc. 1.2% 4,632,149 0% 41% $119,648,409
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 4,312,432 +42% 0.02% $111,390,108
GOLDMAN SACHS GROUP INC 0.83% 3,179,749 -6.6% 0.01% $82,132,928
BANQUE PICTET & CIE SA 0.81% 3,130,724 -0.07% 0.81% $80,866,601
NORTHERN TRUST CORP 0.76% 2,905,509 -6% 0.01% $75,049,297
FEDERATED HERMES, INC. 0.72% 2,779,001 -3.1% 0.13% $71,781,595
NATIONAL BANK OF CANADA /FI/ 0.7% 2,704,838 +357% 0.08% $69,865,933
Merck & Co., Inc. 0.6% 2,308,190 0% 26% $59,620,548
CITIGROUP INC 0.54% 2,082,040 -15% 0.04% $53,779,093
BARCLAYS PLC 0.52% 2,015,828 -7.8% 0.02% $52,068,838
CITADEL ADVISORS LLC 0.52% 1,987,731 +8.3% 0.04% $51,343,091
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.51% 1,960,968 -35% 0.01% $50,651,803

Institutional Holders of Moderna, Inc. - COMMON STOCK (MRNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 657,593 $19,481,870 -$1,270,925 $29.49 37
2025 Q3 274,563,704 $7,091,157,324 -$451,925,470 $25.83 626
2025 Q2 291,423,621 $8,041,462,409 +$359,301,170 $27.59 663
2025 Q1 278,660,879 $7,898,813,961 -$59,278,599 $28.35 675
2024 Q4 276,513,445 $11,496,358,711 +$498,242,513 $41.58 721
2024 Q3 256,693,845 $17,141,220,718 -$821,160,341 $66.83 765
2024 Q2 261,770,303 $31,081,249,299 +$415,637,131 $118.75 937
2024 Q1 258,746,579 $27,572,294,314 +$210,315,080 $106.56 890
2023 Q4 926,644 $92,115,900 +$8,554,575 $99.45 21
2023 Q3 242,676,771 $25,061,422,492 -$390,763,989 $103.29 850
2023 Q2 243,717,634 $29,616,698,086 -$850,131,391 $121.50 926
2023 Q1 244,653,027 $37,553,441,457 +$87,560,567 $153.58 976
2022 Q4 247,606,486 $44,485,667,507 +$356,823,396 $179.62 1,029
2022 Q3 242,017,398 $28,625,052,537 +$336,679,287 $118.25 857
2022 Q2 244,010,599 $34,836,190,373 -$409,618,342 $142.85 940
2022 Q1 244,747,054 $42,165,719,834 +$557,447,518 $172.26 963
2021 Q4 240,528,848 $61,046,373,227 +$682,705,458 $253.98 1,062
2021 Q3 242,703,410 $93,377,691,246 +$6,739,591,856 $384.86 1,113
2021 Q2 207,777,695 $48,813,776,485 +$5,169,599,408 $234.98 866
2021 Q1 188,669,379 $24,691,522,039 +$2,711,203,836 $130.95 753
2020 Q4 168,124,574 $17,562,895,549 -$522,664,847 $104.47 672
2020 Q3 204,615,301 $14,470,118,235 -$1,021,479,918 $70.75 526
2020 Q2 217,433,217 $13,955,557,692 +$1,639,150,845 $64.21 469
2020 Q1 190,036,694 $5,692,045,262 +$497,302,583 $29.95 274
2019 Q4 169,301,323 $3,311,146,090 +$261,075,361 $19.56 152
2019 Q3 105,273,717 $1,675,885,941 +$424,972,286 $15.92 129
2019 Q2 143,250,296 $2,096,223,867 +$128,885,901 $14.64 125
2019 Q1 138,222,036 $2,798,744,442 +$99,819,208 $20.35 101
2018 Q4 133,583,425 $2,019,179,000 +$2,019,010,863 $15.27 74